Immunocytochemical localization of oxytocin in corpora lutea and luteinized cysts from anoestrous ewes stimulated with gonadotrophin-releasing hormone.
Anoestrous Romney Marsh ewes with or without progesterone pretreatment were injected with multiple low-doses of gonadotrophin-releasing hormone followed by a single, larger bolus. Blood samples were taken at twelve-hourly intervals for progesterone radioimmunoassay. Ewes were slaughtered on day 3 or 5 after the bolus injection, and the ovaries were collected for histology and immunocytochemical examination for oxytocin-immunoreactivity. The corpora lutea of all ewes killed on day 3 had similar weights and morphology. The ovaries of those ewes which were not pretreated with progesterone also contained some luteinized cysts. Ewes slaughtered on day 5 were separated into 2 groups according to plasma progesterone profiles, which were either rising ('normal'), or falling after a transitory rise ('abnormal'). Those ewes pretreated with progesterone all had a 'normal' progesterone profile whereas, of 14 ewes not pretreated with progesterone, 6 were 'normal' and 8 'abnormal'. Corpora lutea were significantly lighter in the 'abnormal' group and the ovaries of most of these ewes also contained luteinized cysts. All corpora lutea and luteinized cysts showed staining for oxytocin-immunoreactivity although the staining intensity was variable. In corpora lutea from 'normal' ewes oxytocin was restricted to large luteal cells. In addition tissues from 'abnormal' ewes also contained many cells with an atypical elongated shape which stained for oxytocin-immunoreactivity. These results show that progesterone pretreatment is needed for both normal morphological and endocrine development of corpora lutea in anoestrous ewes stimulated with gonadotrophin-releasing hormone.
Gilbert
C L
CL
University of Bristol, Department of Anatomy, Medical School, United Kingdom.
Hunter
M G
MG
Southee
J A
JA
Wathes
D C
DC
D000780:Anestrus / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D003338:Corpus Luteum / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D015237:Dinoprost / Q000031:analogs & derivatives / Q000032:analysis; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000494:pharmacology*; D007150:Immunohistochemistry; D009929:Organ Size; D010121:Oxytocin / Q000096:biosynthesis*; D011374:Progesterone / Q000096:biosynthesis; D012756:Sheep
C008228:15-keto-13,14-dihydroprostaglandin F2alpha; D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone; D010121:Oxytocin; D015237:Dinoprost